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In  the  late  summer of  1949 cases of  what  was  generally  assumed  to be 
abortive  or  non-paralytic  poliomyelitis occurred  in  and  around  Worcester, 
Massachusetts.  In cooperation with  the Division of Communicable Diseases 
of the Health Department of the Commonwealth of Massachusetts, epidemio- 
logical and laboratory studies were initiated  in an effort to determine more 
precisely the  etiology of the  disease.  The  recent  investigations  of Dalldod 
(1) and of Melnick (2--4) and their collaborators have resulted in the isolation 
of numerous  virus  strains  from patients  suffering  from  illnesses  resembling 
abortive poliomyelitis in various parts of the country. These agents are charac- 
terized  by their  limited pathogenicity for laboratory animals,  since suckling 
mice and hamsters and immature cynomolgus monkeys (5) are the only species 
proven  to be susceptible so far.  Most of the strains  produce lesions  in  the 
skeletal  musculature,  leaving  the  CNS  and  other  viscera  unscathed.  With 
other strains, lesions  involving the brain and the myocardium and other vis- 
ceral organs have been mentioned, though not described in detail. Serological 
evidence suggests the existence of at least several apparently distinct  types 
(6-8).  Since the clinical  features of the Worcester cases resembled those ex- 
hibited by the patients from whom Dalldorf et al. (1) and Meinick et al. (2-4) 
had isolated their strains, attempts were made to isolate a similar agent from 
the Worcester cases.  Two viral agents were isolated and propagated in series. 
The present communication deals with the isolation of one agent and with a 
description of its more obvious biological  properties. Of considerable interest 
are the unusual pathological lesions which it causes in animals, and these are 
described in some detail in the accompanying paper (9). In addition its sero- 
logical relationship to members of the so called Coxsackie group (10) of viruses, 
and certain other agents has been investigated. 
*Aided by a grazlt from The National Foundation for Infantile Paralysis. 
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Source of the Virus 
During the month of September, 1949, approximately 30 patients admitted to the 
Belmont Hospital,  Worcester,  Massachusetts,  with  the  diagnosis of  non-paralytic 
poliomyelitis were studied. Although all cases came from Worcester or its neighbor- 
ing communities, epidemiological investigations failed to  reveal  any demonstrable 
connection  between the individual  cases. The characteristic symptoms were headache, 
fever, and lassitude of  several days'  duration, together  with complaints of  a  stiff 
neck. Physical examination revealed no muscle weakness, but in some cases signs of 
mild meningeal irritation were observed. The results of various laboratory examina- 
tions were essentially normal with one consistent exception; the spinal fluid showed 
a  mild pleocytosis (I00 to 200 cells per c. ram.) which was essentially lymphocytic 
in nature. Recovery was  prompt,  uncomplicated, and  uneventful and no residual 
muscle weakness was noted. Stool specimens obtained as soon as possible after ad- 
mission were  secured from each patient. Blood specimens in the acute and conva- 
lescent phases were also collected  for serological  studies. 
From the stool of one patient (Powers)  a viral agent was isolated, and the clinical 
history of this case is given in more detail. An agent was also isolated from the stool 
of another patient (Matulaitis) hospitalized in the same period because of a  similar 
syndrome. We have only recently been able to propagate it in series, and further work 
must be carried out before it can be identified. It is interesting to note that during 
this  same  period  numerous cases  of  clinically typical  poliomyelitis with  definite 
paralysis were  admitted to the hospital. Materials  for laboratory studies were  not 
obtained from these cases. 
Case H/~tory.--Powers, an 8 year old white girl was admitted  because of headache of 4 
days' duration, accompanied by nausea, sore throat,  and pain in the back of the neck for 24 
hours prior to admission. Some degree of fever had been present. Her past history was non- 
contributory. Physical examination revealed a mildly ill child in no distress. The temperature 
was  100.4°F., pulse  110, and respirations 24. Abnormal physical findings were limited  to 
slight injection of the pharynx and interscapular pain on anterior flexion of the neck. Labo- 
ratory data included a  slight anemia (3.9 million RBC per c. ram. Polymorphonueiears, 53, 
lymphocytes, 41, monocytes, 4, eosinophfls, 2). Urine analysis was essentially normal and 
no pathogenic organisms were found in a throat culture. Lumbar puncture on the day fol- 
lowing admission yielded clear, colorless spinal fluid with a white cell count of 85 per c. ram. 
99 per cent of the cells observed were described as lymphocytes. No bacterial organisms were 
demonstrated  by smear or culture. The patient was treated  symptomatically, and she be- 
came afebrile the day after admission. No spasm or weakness of any muscle group was rec- 
ognized. She was discharged asymptomatic  on the  15th hospital  day with a  diagnosis of 
poliomyelitis, non-paralytic. When examined a month later no evidence of muscle weakness 
could be detected. 
Materials and Methods 
Stool specimens were obtained  as soon as possible after admission. These were stored in 
the refrigerator  at 4°C. until they could be brought to the laboratory--usually a matter of 
several days. The fecal  material was then frozen in its  original  state  or as a 20 per cent emul- 
sion and stored in a C02 cabinet at -70°C. until  the time of inoculation. 
Blood was drawn from each patient as soon as possible  after  admission, and again at time 1~.  S.  CHEEVER, J.  B.  DANIELS, AND E.  1~.  HERSEY  155 
of discharge--usually  about 2 weeks later. In the case of Powers a third specimen was drawn 
a month after her admission to the hospital Late convalescent bloods were likewise obtained 
from several other patients.  These specimens reached the laboratory  as clotted  blood or as 
serum. The serum was pipetted  off after centrifugation and stored at -20°C. 
The preparation  of fecal specimens for inoculation followed in general the technique out- 
lined by Melnick el al. (2-4). A 20 per cent suspension in saline was made by grinding the 
fecal material  with mortar and  pestle. The suspension was then spun at 3,000 a.P.~,  in a 
horizontal centrifuge. The superuatant  fluid was pipetted off and centrifuged in an angle head 
at 18,000 R.P.~. for 30 minutes at 2-4°C. The supernatant  was removed and to it was added 
penicillin and streptomycin to make a final concentration of 1000 units and 1000 micrograms 
per ml. respectively. One litter  of mice not older than 48 hours was inoculated  with each 
specimen by the intraperitoneal  route.  The size of the inoculum was 0.01 to 0.02 ml. Mice 
were observed for 3 weeks before being discarded as negative. At least one blind passage, 
harvesting  brain or carcass, was made with each negative specimen and from nearly every 
Utter at least one mouse was sacrificed for pathological examination. 
Experimental Observations 
One  stool  specimen  from  each  of  19  patients  with  the  diagnosis  of  non- 
paralytic poliomyelitis was studied. In 17 instances no virus was isolated. From 
two specimens  (patients Powers and Matulaitis)  viruses were isolated.  In the 
first  case,  from  the  stool  specimen  obtained  during  the  acute  phase  of  the 
disease  (5  days after  onset  of symptoms),  a  viral  agent  was  isolated  which 
produced obvious signs of illness in infant mice followed by death. The lesions 
included myocarditis, adipositis,  inflammatory and degenerative lesions in the 
brain, and pancreatitis. These lesions are described in detail in the accompany- 
ing paper  (9). No lesions involving the skeletal musculature have been found 
to date. Their absence stands in contrast to the findings reported by Dalldorf 
et al.  (1, 6)  and by Melnick et al.  (2-4).  No difficulty was experienced  in es- 
tablishing  the virus  in mice.  A  sharp  age susceptibility  was noted  however. 
Attempts to isolate the agent from a second stool specimen brought in 1 month 
after  the patient's discharge from the hospital  failed. 
In  the  second case,  Matulaitis,  a  viral  agent  was  isolated  from the  stool 
specimen obtained  1 day after admission  to the hospital  (again 5  days after 
the  onset  of clinical  symptoms).  Its biological characteristics  have not been 
studied  in  detail.  This  agent  causes  lesions  of the  heart,  brain,  and  fat,  as 
well  as  myositis  but  as  yet  no  lesions  have  been  found  in  the  liver  or 
pancreas  (9). 
Incubation  Period.raThe first litter  was inoculated when  1 day old with a 
20 per cent stool suspension from Powers by the intraperitoneal  route.  These 
mice remained well until  the morning of the 6th day at which time one was 
discovered in a  moribund state,  while a  second animal  showed gross tremors 
of the  extremities.  Both  were sacrificed  to secure  material  for passage.  The 
remainder  of the  litter  remained  well  during  4  weeks.  Subsequent  passages 
have been accompanied by a  gradual shortening of the incubation period. By 
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The first signs of illness were usually slight tremors of the extremities, which 
became  more pronounced  until  the  entire  animal appeared  to  shake  as  it 
attempted to raise itself or to move around. Accompanying the tremors were 
weakness,  cyanosis  and  gasping  respiration,  and  frequently retardation of 
growth. Death usually ensued within 48 hours of the development of signs but 
occasional animals survived for several days longer. Although apparent paraly- 
sis Of the extremities  has been  observed  it has not been  a  frequent finding. 
Mice surviving the inoculation of higher dilutions of virus sometimes appeared 
stunted, and showed transient incoordination. 
Route of Inoculation.--Although  the intraperitoneal method of inoculation 
has been our standard procedure  a few animals have been inoculated by the 
intracerebral route. These mice---4 and 5 days old at the time of inoculation 
TABLE I 
Age Susceptibillty 
Age of litter at time of inoculation 
days 
3 
4 
5 
6 
7 
8 
No. showing signs of illness and pathological 
evidence of disease 
719 
3/9 
0/s 
0/9 
0/9 
0/9 
--developed typical signs 72 hours later. They were sacrificed when moribund 
in order to obtain material for pathological  examination. The lesions observed 
did not differ essentially  from those found after intraperitoneal inoculation, 
except for the more frequent occurrence of liquefaction  necrosis of the brain. 
Age Susceptibility.--Both  DaUdorf el  al.  (1)  and Melnick et  al.  (2)  have 
pointed out the marked correlation  between the age  of the animal and its 
susceptibility. Our agent differs somewhat from the Coxsackie group of viruses 
in this respect  inasmuch  as we have had no consistent success in producing 
lethal infections in mice by the intraperitoneal route after the 3rd day of life. 
The results of a typical experiment  are given in Table I. 
Older  mice  (7  to  22  days)  inoculated by several  routes  (intraperitoneal, 
intramuscular, intracerebral)  have failed to develop signs of infection, although 
CNS lesions and adipositis  have been noted on pathological examination in 
some instances. 
Resistance  of Virus to Pkysical and Chemical Agents.--Observations  on the 
resistance of the virus to physical and chemical agents are limited. It has been 
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at least 12 hours at 4°C., and for at least an hour at room temperature. After 
18 hours' exposure to a saturated solution of ether at 4°C. the virus was still 
infectious. 
Bacterial  C¢tltures.--Repeated  attempts to  isolate  a  bacterial agent from 
infected material have been unsuccessful. The media routinely employed in- 
cluded blood  agar plates and tryptic digest broth for aerobic  cultures, and 
thioglycollate broth (and occasionally cooked meat tubes)  for anaerobic  cul- 
tures.  Pleuropneumonia-like  agents have  not  been  demonstrated using  the 
techniques outlined by Dienes (11). 
Filtration  Experiments.raThe  agent passed  readily through a sintered glass 
Coming "UF" falter which retained a culture of Bacillus prodigiosus. 
Reisolation  of the Virus.MTwo months after the first isolation of this virus 
a second attempt was made to obtain it from the same stool specimen. This 
had been stored at  --70°C.  in the form of a  20 per cent saline suspension. 
TABLE  II 
Virus Titration 
Virus Dilutions 
Pasaase  Material  LD,o  NO. 
10"  I0  "~  10"t  10-4  10-4  [  10-4  10"-¢  I  10t  10-0 
7  Brain  9/9  7/7  6/6  3/9  0/10 !  0/7  0/9  I  ....  10_s.  ~ 
12"  Carcass  9/9  9/9  9/9  56/36  75/75 53/66  22/66  0/24  0/9  10  -6.s 
* 9 titrations. 
Two day old mice inoculated intraperitoncally with the thawed material re- 
mained well for 1 week. When, however,  they were autopsied at the end of 
this time typical gross and microscopic pathological lesions were found. Fur- 
ther passage of this material resulted in the development of signs of the disease 
in  7 of 16 suckling  mice inoculated, and the typical gross and microscopic 
lesions were found. 
Localization  of  Viru~.--The  inoculum used in the first five passages  con- 
sisted of a suspension of ground up brain and cord. In the next five passages 
brain  suspension  alone was employed.  Mice  inoculated with  tenth passage 
material were sacrificed when moribund, the gastrointestinal tract was removed 
and discarded, and the carcasses  ground in phosphate buffer  to make a  20 
per cent suspension.  Penicillin  and streptomycin were added to give a  final 
concentration of 2,000 units and 2,000 micrograms per ml., respectively.  After 
light centrifugation the superuatant was removed and used as passage material. 
Typical gross and microscopic lesions were noted at autopsy of passage mice. 
Since the titer of virus appeared to be fully as high in carcass as in brain the 
former has subsequently been used as passage material. The results of titrations 
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the  inoculum was  0.02  ml.  of  tenfold dilutions in isotonic phosphate buffer 
at pH 7.1  and the route was intraperitoneal. 
In one experiment mice were sacrificed when moribund, the  interscapular 
fat was dissected out, pooled, and ground in phosphate buffer to make a  I0 
per cent suspension. Three day old mice inoculated intraperitoneally with this 
material sickened and died within 72 hours, and at autopsy typical lesions were 
observed.  No  other  specific tissues have been examined for  the  presence of 
virus, but since heparinized heart's blood was also found to be infective pre- 
sumably the virus is widely distributed throughout the body. 
Host Range.--A litter of day old guinea pigs inoculated by the intracerebral 
or intraperitoneal route remained well. One day old voles inoculated by the 
same routes succumbed within 72 hours and virus was demonstrated in their 
brains by subinoculation into mice.  Further serial passages  in voles will be 
required in order to prove that this species is susceptible. A monkey inoculated 
by the intracerebral route showed no signs of disease and serological studies 
showed  no neutralizing antibody but a  greater  than  16-fold rise in comple- 
ment-fixing antibody. Attempts to infect embryonated eggs by various routes 
have been unsuccessful. 
Serological Tests 
Methods.-- 
.Preparation of Sera.--Young adult mice were immunized by a series of 3 intramuscular 
injections of 0.1 to 0.2 ml. of a 40 per cent suspension of infected carcass given at weekly 
intervals. The animals were bled out 1 to 2 weeks later and the serum was separated, pooled, 
and stored at -20"C. Normal mice of a comparable age were bled out and the pooled nor- 
mal serum was stored under similar conditions. A monkey that had survived an intracerebral 
inoculation of the virus was immunized by a series of intramuscular  injections and subse- 
quently bled as an additional source of immune serum. 
Preparation of Antigen for Complement Fixation.--Suckling mice 1 to 2 days of age were 
inoculated intraperitoneally with a 10  -~ suspension of infected mouse carcass. The animals 
were sacrificed when moribund approximately 48 hours later. The gastrointestinal tract was 
dissected out and discarded. The carcasses were then ground in a Waring blendor with 0.85 
per cent saline to make a 20 per cent suspension, and stored at -20°C. for2 to 3 days. The 
suspension was thawed and then centrifuge  d for 30 minutes in the horizontal head at 3,000 
R.P.~. The supernatant was pipetted  off and diluted with an equal amount of 0.85 per cent 
saline. Ether was added to give a final concentration of 33 per cent by volume, and after a 
few minutes' careful shaking the resulting mixture was permitted  to stand at 4°C. for 16 
hours in a separatory funnel. The ether layer was discarded and residual ether was removed 
from the aqueous phase by means of a vacuum pump. The suspension was then centrifuged 
at 18,000 R.p.~. for 20 minutes in an angle head at 2°C. and the pellet discarded. The super- 
natant was frozen and stored at --70°C. until use. 
Hemolytic System.--A given volume of a  2 per  cent  suspension of sheep erythrocytes 
(washed three times) was mixed with an equal amount of diluted anti-sheep cell rabbit serum 
containing 2 units of amboceptor and placed in a 37  ° water bath for 10 minutes. These sen- 
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Complement.--Sera from 6 to 9 guinea pigs were collected, pooled, and stored in the COs 
box until use.  The complement was always titrated  in the presence of the antigen on the 
morning of each test run. 
Titration of Complement Fixation Antigen.--Twofold dilutions of antigen in isotonic veronal 
buffer at  pH  7.3  were prepared  and  titrated  against  twofold dilutions of a  hyperimmune 
mouse serum.  The highest dilution of antigen giving complete fixation with 4  units of the 
antibody was regarded as I antigen unit. The unit of antibody was arbitrarily considered to 
be the highest dilution of the serum giving complete fixation with the undiluted antigen. In 
the complement fixation test 8 units of antigen were employed. 
Technique of Complement Fixation Tesl.--The  sera inactivated at 560C. for one-half hour 
were diluted 1:2 to 1:512. To 0.1 ml. of each dilution of serum to be tested 2 units of com- 
plement in a volume of 0.1 ml. was added, and finally 0.1 ml. of antigen (containing 8 anti- 
gen units).  After thorough  shaking  the tubes were placed  in  the refrigerator at 4°C.  and 
permitted to stand  overnight (approximately 16 hours).  The next morning 0.2  ml. of sensi- 
tized sheep red blood cells was added to each tube. After incubation for 30 minutes in a water 
bath at  37°C. the results were read.  Complete fixation is recorded as 4+.  The end-point 
selected was the last tube to give to 3+ fixation of complement, Veronal buffer was used as 
diluent throughout. 
Technique of Neutralization Test.--All  sera were inactivated by treating at 560C. for 30 
minutes just prior to use.  In general undiluted and diluted serum was mixed with an arbi- 
trarily selected amount of virus. This was estimated to approximate 100 LD~ or 500 LD~0 
per 0.02 ml. (final  dilution) but the exact amount varied slightly from one test to another. 
The titer of the virus was confirmed at the time each test was performed by inoculation of 
the pertinent dilutions of virus into litters of mice. 
Equal amounts (usually 0.15 ml.) of serum (undiluted and diluted 1:5 and 1:50 in phos- 
phate buffer) and of the diluted virus were mixed and permitted to stand at room temperature 
for 30 minutes. The tubes were then put in an ice water bath and inoculated as soon as pos- 
sible into suckling mice. For this purpose litters less than 48 hours old were selected and 
pooled, and the animals distributed at random to minimize the possible  effects of individual 
susceptibility. As a general rule 7 or 8 young were given to each mother, and one group was 
injected  intraperitoneaUy  with  each  virus-serum  mixture--or  virus  dilution.  The  amount 
injected was 0.02  ml. per animal. The mice were examined daily for 2 weeks.  In some in- 
stances when the amount of serum available was small the lowest dilution tested was 1:5. 
Results.-- 
Neutralization Tests.--Convalescent serum specimens  from 18 patients in the 
Worcester group were tested for the presence  of neutralizing  antibodies.  In 9 
cases  no  neutralizing  antibody  could  be  detected,  while  in  9  others  it  was 
demonstrated.  Acute  and  convalescent  serum  specimens  from  each  patient 
showing a  positive result in the screening procedure were tested simultaneously 
in an effort to demonstrate a  significant rise in antibody titer during the course 
of the patient's illness. In most instances the results were clear cut; if antibody 
could  be  demonstrated  in  the  convalescent  serum  specimen  an  essentially 
equivalent titer could be demonstrated  in the acute specimen. In only one case 
was it possible to show any rise in antibody  level (Table III). When late con- 
valescent  serum  specimens  were available  these  were  tested  as  well, and  the 
results  obtained  were entirely similar  to  those described  above. 160  VIRAL  AGENT FROM NON-PARALYTIC POLIOMYELITIS 
Of the two patients from whom a virus was isolated, one (Powers) showed 
neutralizing antibodies against her own agent in all 3 serum specimens. The 
early convalescent  serum specimen showed slightly greater neutralizing effect 
than either the acute or late convalescent one. The other (Matulaitis), had no 
demonstrable neutralizing antibodies in either the acute or convalescent phase 
serum specimen against the virus isolated from Powers (Table III). 
The incidence of neutralizing antibody to the Powers agent in adults, normal 
or with other disease, was investigated. Of surgical cases from a clinic serving 
a wide area 14 out of 20 showed neutralizing antibody; of cases of multiple 
sclerosis 6 out of 7, and of laboratory personnel 3 out of 7 (one with history of 
"non-paralytic  poliomyelitis") neutralized the virus. This control group totalled 
23 positive out of 34 tested. 
TABLE III 
Neutralization Tests: Sera of Patients J. P. and ]. M. 
Pa~ent 
J. P. 
l, 
II 
.l.,,lVi. 
Serum 
Acute phase 
Early  conva- 
lescent phase 
Late  cony. 
phase 
Acute phase 
Cony.  " 
Challenge 
dose of 
Powers virus 
10 LDso 
,if  l¢ 
,¢  II 
1:40 
6/7~ 
9/9 
717 
0/6 
0/8 
Serum dilutions* 
1:160 
3/7 
818 
719 
0/6 
0/6 
1:320 
6/7 
7/7 
6/7 
0/6 
0/7 
1:540 
0/8 
3/6 
s/s 
Unsat. 
o/s 
1:1280 
13/7 
i 
5/6 
! 
0/8 
o/6 
o/8 
1:2560 
0/8 
5/8 
0/8 
0/8 
O/7 
Results 
--m 
Positive 
Negative 
* Final dilutions. 
No. survivors 
:~ No. inoculated 
Through the courtesy of Dr. Enders and Dr. Weller paired sera from 3 cases 
of epidemic pleurodynla were made available.  The first case (McGoff) showed 
some possible rise in antibody titer against approximately 700 LDs0 of virus. 
The second case (McLaughlin) had no demonstrable antibodies in the uudiluted 
acute serum specimen, but the convalescent serum gave complete neutralization 
even when diluted 1:100  and against the same  virus challenge  dose.  Une- 
quivocal neutralization could not be demonstrated in either the acute or con- 
valescent serum (diluted 1:10) of the third case (Koch) tested (Table IV). 
Specific antisera against certain neurotropic viruses (other than members of 
the Coxsackie group) have been tested for their ability to neutralize the agent. 
The antisera tested included Mengo, Columbia SK, and GD VII. The results 
have been uniformly  negative as demonstrated by the protocol given in Table 
V. 
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and various members of the Coxssckie group of viruses were investigated by 
means of the neutralization, complement fixation, and cross-immunity tests. 
The following strains of Coxsackie  virus were obtained through the kindness of Dr. J. L. 
Melnick: Ohio R, Connecticut 5, and High Point. Mice were immunized against these agents 
as well as against the Powers virus. Through the kindness of Dr. Enders and Dr. Weller, a 
sample of specific antiserum made by hyperimmunization of mice against the DeMole virus  ] 
TABL[  IV 
Neutrali~tion Tests with Sera  'ram Cases of Pleurodynia 
Patient  Serum 
Acute phase 
Cony.  44 
Acute  " 
ConY.  44 
Acute  " 
Cony.  44 
No. 88 
(McGoff) 
No. 90 
(McLaughlin) 
No. 42 
(Koch) 
Day of 
illness  serum 
collected 
3 
15 
1 
14 
4 
14 
Challenge 
dose of Powers 
virus 
700 LD~o 
44  44 
~C  4g 
~4  44 
44  t¢ 
C4  44 
Serum dilutions* 
1:10  1:100 
3/8~  018 
7/8  0/8 
0/8  o/8 
7/8  7/8 
0/8  0/8 
2/6  0/8 
Result 
Doubtful 
Positive 
Negative 
Positive 
Negative 
Doubtful 
* Final dilutions. 
No. survivors 
No. inoculated  ~ 
TABLE V 
Neulrallzalion  Tests u,ith Specif~ Antlsera 
Antiserum 
Mengo 
CoL SK 
GD VII 
Powers 
Normal mouse serum 
Challenge 
dose of Powers 
virus 
700 LD~o 
~  44 
~4  44 
4d  44 
c4  44 
Serum dilutions* 
1:2  1:100 
o/85  0/8 
0/8  0/8 
o/8  0/8 
7/7  6/8 
0/8  Not done 
Result 
Negative 
4g 
4¢ 
Positive 
Negative 
* Final dilutions. 
No. survivors . 
$ No. inoculated 
was made available to us. As an additional check, Dr. Meinick generously furnished us with 
a sample of his own Connecticut 5 antiserum for the first experiment. These five specific sets 
and a  control normal mouse serum were tested for their ability to neutralize approximately 
50 LDso of Powers virus. 
The results are recorded  in Table VI. No neutralization was demonstrated 
by any antiserum except the Powers specimen. This antiserum g~ve complete 
neutralization in a dilution of 1:100 against the homologous virus. 
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These five antisera just mentioned were tested for their ability to neutralize 
the Connecticut 5 virus. Here again the results were unequivocal (Table VII). 
A definite neutralizing effect was exerted by the DeMole antiserum and by both 
Connecticut  5  antisera.  The  Powers  antiserum,  Ohio  R  antiserum,  and  the 
normal mouse serum failed to neutralize.  Thus once more we were unable to 
Neutralisation Tests wit, 
Antiserum 
Connecticut 5 (Melnick) 
Connecticut 5 (Cheever) 
DeMole 
Ohio R 
Powers 
Normal mouse 
TABLE VI 
Powers Virus and Specific Antisera (Coxsackie Group) 
Challenge 
dose of Powers 
virus 
50 LDso 
1:10 
0/8~ 
0/8 
o/7 
0/7 
8/8 
0/7 
Serum dilutions* 
1:100 
0/8 
0/8 
0/8 
o/8 
8/8 
Not done 
1:1000 
o/8 
018 
0/8 
0/8 
6/7 
Not done 
Highest 
serum dilu- 
tion giving 
complete 
protection 
<10 
<10 
<10 
<10 
I00 
<10 
* Final dilutions. 
No. survivors 
No. inoculated" 
TABLE VII 
Neutralization Tests ~vltk Connecticut 5 Virus and Specific Antlsera (Coxsackie Group) 
Antiserum 
Connecticut 5 (Melnick) 
Connecticut 5 (Cheever) 
DeMole 
Ohio R 
Powers 
Normal mouse 
Challenge 
dose  of 
Connecticut 
S  virus  1:10 
200  LD6o 
"  "  7/7 
....  8/8 
....  0/8 
"  "  0/8 
....  0/8 
Serum dilutions* 
1:100 
9/9 
8/8 
8/8 
0/8 
0/S 
Not done 
1:1000 
1/s 
6/8 
7/7 
0/8 
o/8 
Not done 
Highest 
serum d ilu. 
tion giving 
complete 
protection 
100 
100 
>1000 
<10 
<10 
<10 
* Final dilutions. 
No. survivors. 
No. inoculated 
demonstrate a  serological relationship between the Powers and Connecticut 5 
strains,  although  the  latter  appeared  to  be  imraunologically  similar  to  the 
DeMole strain of Weller and Enders.  2 
t Dr. Melnick kindly tested our Powers and Connecticut 5 antisera against his Easton and 
Connecticut  5 virus strains.  Neither  serum gave any protection  against  the Easton strain. 
The Connecticut 5 virus was neutralized by the homologous antiserum, but not by the Powers 
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A number of mice apparently protected by serum antibodies against ordi- 
narily lethal challenge doses of virus were sacrificed at the end of the experiment 
for pathological examination. In general the correlation between obvious illness 
and pathological findings was good; i.e., mice that survived and showed no 
sign of sickness presented little or no pathological evidence of infection. Oc- 
casionaUy healed calcified lesions were noted in  the myocardium, or in  the 
adipose tissue, or in both. Conversely, an occasional mouse thought to show 
some sign of illness at the end of the observation period failed to show any 
anatomical evidence of infection at autopsy. Mice that developed signs of the 
disease after inoculation of serum-virus mixtures showed typical lesions. 
TABLE  VIII 
Complement Fixation Tests with Spe¢if~ A ntisera 
Antiserum 
Connecticut 5 (Melnick) 
Connecticut 5 (Cheever) 
DeMole 
Ohio R 
High Point 
Powers 
Normal mouse serum 
Antigen 
Connecticut  5  Powers 
32 
32 
32 
16 
8 
512 
0 
32* 
128 
128 
8 
4 
0 
0 
Normal mouse 
tissue 
* Reciprocal of initial serum dilution giving a 3+ reaction. 
Coraplement Fixation  Tests.--When the hyperimmune mouse sera were tested 
for  complement-fixing antibody in  the  presence  of  Powers  antigen  and  of 
Connecticut 5 antigen the results as shown in Table VIII tended to comfirm 
those obtained by the neutralization test. The Powers strain does not appear 
to be closely related to the Ohio R, High Point,  Connecticut 5,  or DeMole 
strains  although the  latter  two  seem  to  be  immunologicaUy similar  if not 
identical. 
A rise in complement-fixing antibody was demonstrated in the same patients 
in whom a  rise in neutralizing antibody was shown, namely Powers, McGoff, 
and Me.Laughlin (Table IX). Of the remaining Worcester patients, two were 
negative, one reacted with normal tissue, and 15 showed a  constant level of 
complement-fixing antibody when acute phase sera and one or two convalescent 
sera were compared. A control group of human sera showed a high incidence of 
complement-fixing antibody. 
Cross-Immunity Tests.mA group of female mice was immunized against the 
Powers virus by a  series of intramuscular injections as previously described, 
and bred. Other groups were similarly immunized against the Connecticut 5 TABLE  IX 
Complem~t Fixation: Pati~ts Sttowing Rise in Antibody  Titer 
Patient  Powers antigen  Powers neutralization 
Powers  acute 
~  conv. 
"  late  cony. 
McGoff 88-A  acute:~ 
"  88-B conv. 
McLaughlin 90-A acute~ 
"  90-B conv. 
8* 
54 
32 
128 
512 
<64 
>512 
Positive 
Doubtful 
Positive 
Negative 
Positive 
All sera from a  given patient were tested simultaneously. 
* Reciprocal of initial serum dilution giving a 3-{- reaction. 
Clinical diagnosis epidemic pleurodynia. 
TABLE  X 
Cross-Immunity  Tests: Challenge of Passirdy Immunized Litters 
Group  I. Immunized  against Powers vires 
Inoculum  (LD.I) 
Challenge vires 
Powers 
Connecticut 5 
Ohio R 
High Point 
,o  Io_, lo_. t  1~  1o_.[ ,o_,  Unde- 
termined 
o/5 
0/6 
Group II. Immunized against Connecticut 5 virus 
Inolulum (LDse) 
Challenge virus 
Powers 
Connecticut 5 
Ohio R 
High Point 
11olo  o  lo  o  lole~ 
5/7  o/6 
--  --  6/6 
2/7 
0/6 
Group III. Immunized against DeMole vlms 
Inoculum (LDie) 
Challenge vires 
Powers 
Connecticut  5 
Ohio R 
High Point 
2/7  0/6  I  0/6  ]  0/5  0/5  0/4  [  - 
....  2/i2 
--  0/12 
,  No. survivors 
No. challenged" 
Deaths in these groups thought to be non-specific. 
154 1~.  S.  C~_RRVERp J.  B.  DANIELS~ AND  E.  ¥.  HERSEY  165 
virus and the DeMole virus. In general the last dose of vaccine was admiuistered 
1 to 2 weeks before parturition. No obvious illness or pathological evidence 
suggesting the transmi~ion of infection in utero  from mother to young was 
Obtained. One to 2 day old litters from each group were then challenged by the 
intraperitoneal inoculation of the homologous virus strains, and of three heter- 
ologons strains as well.  Control litters of normal mice were injected also in 
order to confirm the potency of each inoculum which was actually titrated only 
in the case of the Powers and Connecticut 5 viruses. 
The results are shown in Table X. Litters resisted a large challenge inoculum 
of the homologous agent, but succumbed to a smaller one of each of the heter- 
ologous strains except in the case of the DeMoie and Connecticut 5 strains. 
The serological relationship of the DeMole virus to the other strains is discussed 
in another paper describing the isolation of that agent  (12).  No evidence of 
immunological relationship between the Powers agent and the three Coxsaekie 
strains was obtained by this method. 
DISCUSSION 
The pioneer studies of Dalldoff (1)  and of Melnick (2-4)  have led to the 
definition of a new group of viral agents whose most characteristic biological 
properties are: first, host range limited to suckling mice, hamsters, and certain 
monkeys and  second,  the apparently uniform production  of myositis  (10). 
Individual strains of this group (generally known as Coxsackie or C group of 
viruses) have been isolated from a number of individuals, and in addition from 
extrahuman sources such as sewage and flies. The evidence that they may cause 
clinical disease in man is strong. The agent described in the present communi- 
cation bears certain resemblances to this group of viruses. Suckling mice (and 
perhaps voles) are the only susceptible species noted so far. Some of the patho- 
logical findings resemble those described in connection with the Coxsackie group 
of viruses.  On  the other hand,  the sharper age  limitation (as compared  to 
Dalldorf's findings (1)) and our consistent failure to recognize myositis suggest 
the possibility that this agent may be  one not too closely related  to  those 
previously described. The serological evidence at hand tends to bear this out. 
These findings, pathological and serological, appear to justify  a brief description. 
There appears to be no doubt that our agent is of human rather than murine 
origin. On the positive side is the fact that it has been isolated twice from the 
same stool specimen several months apart. Further evidence stems from our 
inability to isolate a similar agent during the course of many mouse passages 
with negative material. Were such an agent latent in our mice one would have 
expected to pick it up in the course of such manipulations. 
That the agent had some etiological connection with the clinical syndrome of 
patient Powers is probable since a clear cut rise in complement-fixing antibody 
and a slight rise in neutralizing antibody during the course of the illness were 
shown. The presence of one or the other or both antibodies in the remaining 166  VIRAL  AGENT  ~'ROM NON-PARALYTIC  POLIOMYELITIS 
Worcester patients may have no relationship to the disease under investigation 
since a group of control sera revealed  an even higher incidence of both anti- 
bodies.  A correlation  between  neutralizing and complement-fixing antibodies 
was observed only in those cases in which both antibodies rose. There is thus 
neither serological nor epidemiological evidence that the Worcester  cases were 
caused by any single agent. 
In addition two paired  (acute and convalescent  phase)  sera,  kindly made 
available to us by Dr. Enders and Dr. WeUer, showed a rise in complement- 
fixing antibody and at least one pair a rise in neutralizing antibody. In these 
cases the clinical diagnosis was epidemic pleurodynia. 
Me]nick (4) has emphasized the rapidly accumulating  evidence that infections 
with strains of the Coxsackie group of viruses  have occurred  in widespread 
areas of this country. In connection with this it is interesting to note that in 
several instances we have been able to demonstrate antibodies versus the Powers 
strain in the sera  of individuals not known to have suffered  from illnesses 
resembling  those reported by Curnen el al.  (3)  and other investigators. One 
exception to this was normal adult K, who gave a history of having had non- 
paralytic poliomyelitis several years previously. 
The relationship  of the Powers  agent to the  Coxsackie group of  viruses 
remains to be determined. The pathological  similarities  and differences have 
been mentioned and are the subject of a detailed discussion in the accompanying 
paper. The serological evidence at hand so far suggests no relationship to the 
Connecticut  5,  Ohio  R,  and  High  Point  strains  of  Melnick,  and  cross- 
immunity tests bear this out. The significance of a rise in neutralizing antibodies 
in one  case,  and of complement-fixing  antibodies in two  cases  of epidemic 
pleurodynia is not dear. The question of a  possible  serological relationship 
between the Powers  and DeMole and DeMole and Connecticut 5 agents is 
also considered in another paper  (12). It is obvious that further studies are 
required in order to clarify the etiological and serological relationships  of these 
various viruses. 
SUMMARY 
1.  A viral agent, Powers, causing myocarditis, adipositis, pancreatitis, hep- 
atitis, and encephalomyelitis  but not myositis in suckling mice 1 to 2 days old 
has been isolated from the stool of a patient in whom the clinical diagnosis was 
t'non-paralytic poliomyelitis." 
2.  Serological evidence linking the virus to the clinical disease observed was 
clear only in  the  case  of  "non-paralytic poliomyelitis" from which  it was 
isolated. 
3. The possible relation of this agent to the Coxsackie group of viruses is 
discussed.  No serological  relationship with the  Connecticut 5, Ohio R, and 
High Point strains was demonstrated. F.  S.  CHEEVER~ J.  B.  DANIELS~  AND  E.  F.  HERSEY  167 
4.  A second virus, Matulaitis,  has been isolated from a  concurrent  case of 
"non-paralytic  poliomyelitis"  in  the  same  area.  Lesions produced  in  infant 
mice by the two agents show certain differences. 
We are indebted to Miss Thelma LeBlanc and Miss Sheila Richardson for their assistance 
in the biological and pathological studies respectively. 
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